vimarsana.com
Home
Live Updates
Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstoo
Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstoo
Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstood Growth Name.'
Automated insulin technology developer Insulet posts third-quarter revenue of $432.7 million, compared with $340.8 million a year earlier.
Related Keywords
Jim Hollingshead ,
Margaret Kaczor Andrew ,
Emily Dattilo ,
William Blair ,
Jayson Bedford ,
Raymond James ,
,
Dow Jones Market ,
Wall Street ,
Glenn Shell ,
Medical Technology ,
Article Normal ,
Pharmaceuticals ,
Port Harbor Operations ,
Healthcare Life Sciences ,
Specialized Drugs Medications ,
Hormone Products ,
Diabetes Drugs ,
Water Transport Shipping ,
Transportation Logistics ,
Financial Performance ,
Analysts Amp 39 Comments Recommendations ,
Corporate Industrial News ,
Content Types ,
Factiva Filters ,
C Amp Ampe Exclusion Filter ,
C Amp Ampe Industry News Filter ,
Synd ,
Street Notes ,
Healthcare ,
Markets ,
North America ,
Rapid Response ,
Insulet ,
Podd ,
S Amp Ampp 500 Index ,
Spx ,
Analysts Amp 39 Comments ,
Recommendations ,
Corporate ,
Industrial News ,
Port ,
Harbor Operations ,
Life Sciences ,
Specialized Drugs ,
Medications ,
Water Transport ,
Shipping ,
Transportation ,
Logistics ,